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LETTER TO THE EDITOR
Comments on the ‘Editorial on ILD’ published in the September 2016 issue
of JPMA
Ali Bin Sarwar Zubairi
Madam, I had an opportunity to read the editorial on
national guideline and ILD PAK registry report
published in September 2016 issue of JPMA. I
appreciate the effort by Dr. Mosavir Ansarie to develop
the registry. This is the first published data from
Pakistan highlighting the importance of this neglected
disease for decades.
Interstitial Lung Disease (ILD) is a difficult diagnosis
which
requires
multi-disciplinary
approach
comprising a team of trained Pulmonologist,
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Radiologist and Pathologist with special interest in this
disease to work on the registry. Every Pulmonologist is
not expected to be an expert in ILD. The predominant
participating centres were private clinics or
government hospitals in PAK ILD registry are not
identified in the report. To our knowledge, the ILD PAK
registry has data from private centers with significant
limitations.
I wish if the group had a liaison with major tertiary care
centers of Pakistan with an identified key person before
publication of this report so that a larger population
with disease patterns would have been identified. We
need to work together for a better future of patients
with ILD for the prevention and treatment outcomes for
this disease.

